🦠 Broad-Spectrum Antifungal Activity: Effective against various fungal infections, including invasive aspergillosis, candidemia, and infections caused by Fusarium and Scedosporium species.

💊 Dual Administration Options: Available in both oral and intravenous forms, providing flexibility in treatment.

🧬 Mechanism of Action: Inhibits ergosterol synthesis by targeting the CYP450-dependent 14-alpha sterol demethylase enzyme, disrupting fungal cell membrane integrity.

⚖️ Dosing Flexibility: Suitable for patients aged 12 years and older, with dosing adjusted based on body weight and infection severity.

🏭 Trusted Manufacturer: Produced by Incepta Pharmaceuticals Ltd., ensuring consistent quality and reliability.